CARs constructed with acetyl heparinase to degrade the tumor cell ECM and those that target fibroblast-activating protein (FAP) showed superior tumor infiltration and antitumor activity compared to their unmodified CAR counterparts (Wang et al., 2014; Caruana et al., 2015). Here, FAP is linked to neoplasm.